Delos Capital
  • Delos
  • Team
  • Connects
  • Companies
  • News
  • Contact
Select Page

ONCOMYX THERAPEUTICS COMPLETES $25 MILLION SERIES A FINANCING

by Admin | Jun 5, 2019 | Delos News

PHOENIX – June 5, 2019 – OncoMyx Therapeutics, a privately-held oncolytic immunotherapy company founded on the myxoma virus (MYXV) platform from Arizona State University (ASU), announced today the completion of a $25 million series A financing led by Boehringer...
Next Entries »
  • © 2019 Delos Capital Partners / Delos Life Science
  • Privacy Policy
  • Terms of Use
  • Contact